| |
| |
|
| Insider
Information: |
Wentworth Kory James |
| Relationship: |
Chief Financial Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
92,682 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,607 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
92,682 |
|
|
| Total
Value |
$9,607 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -94.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bluebird Bio, Inc. |
BLUE |
|
2020-08-03 |
9,512 |
2018-01-02 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Chief Financial Officer |
2024-03-15 |
83,170 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
OE |
$2.10 |
$18,900 |
D/D |
9,000 |
83,170 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2024-03-06 |
4 |
AS |
$12.31 |
$50,285 |
D/D |
(4,086) |
74,170 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2024-03-05 |
4 |
D |
$12.28 |
$18,062 |
D/D |
(1,471) |
78,256 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2024-03-04 |
4 |
D |
$12.42 |
$9,625 |
D/D |
(744) |
79,727 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,900 |
80,471 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-12-26 |
4 |
AS |
$16.67 |
$1,567 |
D/D |
(94) |
49,571 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-12-26 |
4 |
OE |
$2.10 |
$197 |
D/D |
94 |
49,665 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-12-22 |
4 |
OE |
$2.10 |
$21,433 |
D/D |
10,206 |
59,777 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-12-22 |
4 |
AS |
$15.24 |
$160,124 |
D/D |
(10,206) |
49,571 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-12-21 |
4 |
AS |
$15.07 |
$33,155 |
D/D |
(2,200) |
49,571 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-12-21 |
4 |
OE |
$2.10 |
$4,620 |
D/D |
2,200 |
51,771 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-09-06 |
4 |
AS |
$13.45 |
$12,806 |
D/D |
(950) |
49,571 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-09-05 |
4 |
D |
$14.46 |
$6,161 |
D/D |
(426) |
50,521 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,200 |
50,947 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-07-11 |
4 |
AS |
$18.00 |
$69,904 |
D/D |
(3,884) |
36,747 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-07-11 |
4 |
OE |
$2.10 |
$8,156 |
D/D |
3,884 |
40,631 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-07-10 |
4 |
OE |
$2.10 |
$12,844 |
D/D |
6,116 |
42,863 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-07-10 |
4 |
AS |
$17.98 |
$109,958 |
D/D |
(6,116) |
36,747 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-06-29 |
4 |
OE |
$2.10 |
$18,459 |
D/D |
8,790 |
36,747 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-06-21 |
4 |
AS |
$14.84 |
$262,648 |
D/D |
(17,500) |
27,957 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-06-21 |
4 |
OE |
$2.10 |
$36,750 |
D/D |
17,500 |
45,457 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
AS |
$10.46 |
$18,389 |
D/D |
(1,747) |
42,157 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
D |
$11.60 |
$11,654 |
D/D |
(1,005) |
43,904 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,400 |
44,909 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-03-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
14,200 |
27,957 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
